Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana.
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana.
Biol Psychiatry. 2023 Dec 1;94(11):875-887. doi: 10.1016/j.biopsych.2023.06.002. Epub 2023 Jun 15.
Most efforts in addiction research have focused on the involvement of the medial prefrontal cortex, including the infralimbic, prelimbic, and anterior cingulate cortical areas, in cocaine-seeking behaviors. However, no effective prevention or treatment for drug relapse is available.
We focused instead on the motor cortex, including both the primary and supplementary motor areas (M1 and M2, respectively). Addiction risk was evaluated by testing cocaine seeking after intravenous self-administration (IVSA) of cocaine in Sprague Dawley rats. The causal relationship between the excitability of cortical pyramidal neurons (CPNs) in M1/M2 and addiction risk was explored by ex vivo whole-cell patch clamp recordings and in vivo pharmacological or chemogenetic manipulation.
Our recordings showed that on withdrawal day 45 (WD45) after IVSA, cocaine, but not saline, increased the excitability of CPNs in the cortical superficial layers (primarily layer 2, denoted L2) but not in layer 5 (L5) in M2. Bilateral microinjection of the GABA (gamma-aminobutyric acid A) receptor agonist muscimol to the M2 area attenuated cocaine seeking on WD45. More specifically, chemogenetic inhibition of CPN excitability in L2 of M2 (denoted M2-L2) by the DREADD (designer receptor exclusively activated by designer drugs) agonist compound 21 prevented drug seeking on WD45 after cocaine IVSA. This chemogenetic inhibition of M2-L2 CPNs had no effects on sucrose seeking. In addition, neither pharmacological nor chemogenetic inhibition manipulations altered general locomotor activity.
Our results indicate that cocaine IVSA induces hyperexcitability in the motor cortex on WD45. Importantly, the increased excitability in M2, particularly in L2, could be a novel target for preventing drug relapse during withdrawal.
大多数成瘾研究都集中在涉及内侧前额叶皮层的作用,包括眶额皮层下区、额前皮质区和前扣带皮层区,在可卡因寻求行为中的作用。然而,目前还没有有效的预防或治疗药物复吸的方法。
我们转而关注运动皮层,包括初级运动皮层和辅助运动皮层(M1 和 M2)。通过在 Sprague Dawley 大鼠中进行可卡因静脉自我给药(IVSA),来评估成瘾风险。通过在体全细胞膜片钳记录和在体药理学或化学遗传学操作,来探索 M1/M2 皮质锥体神经元(CPN)兴奋性与成瘾风险之间的因果关系。
我们的记录显示,在 IVSA 后第 45 天(WD45),可卡因而非盐水增加了 M2 皮质浅层(主要是第 2 层,记为 L2)而非第 5 层(L5)CPN 的兴奋性。双侧将 GABA(γ-氨基丁酸 A)受体激动剂毒蕈碱微注射到 M2 区可减弱 WD45 时的可卡因寻求。更具体地说,通过 DREADD(专门由设计药物激活的设计受体)激动剂化合物 21 抑制 M2 中 L2 的 CPN 兴奋性(记为 M2-L2),可防止可卡因 IVSA 后 WD45 时的药物寻求。这种 M2-L2 CPN 的化学遗传抑制对蔗糖寻求没有影响。此外,药理学或化学遗传抑制操作都不会改变一般的运动活动。
我们的结果表明,可卡因 IVSA 在 WD45 时会导致运动皮层过度兴奋。重要的是,M2 中兴奋性的增加,特别是在 L2 中,可能是戒断期间预防药物复吸的新靶点。